Canton Strategic Holdings (CNTN) Cash from Financing Activities (2021 - 2026)

Canton Strategic Holdings (CNTN) posted Cash from Financing Activities of $87.0 million for Q1 2026, down 10.76% on a QoQ basis from $97.4 million in Q4 2025, and up 42200.79% year-over-year from N/an in Q1 2025.

Canton Strategic Holdings (CNTN) Cash from Financing Activities (2021 - 2026) Analysis & Trends

Canton Strategic Holdings' Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $87.0 million for Q1 2026.

  • Quarterly Cash from Financing Activities rose 42200.79% year-over-year to $87.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $193.9 million (up 5579.56% YoY) and the FY2025 annual result came in at $107.2 million, up 2939.54% from the prior year.
  • Cash from Financing Activities was $87.0 million for Q1 2026 at Canton Strategic Holdings, down from $97.4 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $97.4 million in Q4 2025 and bottomed at -$338585.0 in Q3 2022.
  • A 5-year average of $13.1 million and a median of $1.6 million in 2024 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities plunged 485.1% — and 2026, when it surged 42200.79%.
  • Canton Strategic Holdings' Cash from Financing Activities stood at -$193457.0 in 2022, then jumped by 5094.25% to $9.7 million in 2023, then plunged by 81.18% to $1.8 million in 2024, then surged by 5257.28% to $97.4 million in 2025, then dropped by 10.76% to $87.0 million in 2026.
  • Business Quant data shows CNTN's Cash from Financing Activities at $87.0 million in Q1 2026, $97.4 million in Q4 2025, and $7.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Canton Strategic Holdings 427.87 Mn 427.87 Mn - 86.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 86.96 Mn
Mar 31, 2026 86.96 Mn
Dec 31, 2025 97.44 Mn
Dec 31, 2025 97.44 Mn
Sep 30, 2025 7.22 Mn
Sep 30, 2025 7.22 Mn
Jun 30, 2025 2.31 Mn
Jun 30, 2025 2.31 Mn
Mar 31, 2025 205,568.00
Mar 31, 2025 205,568.00
Dec 31, 2024 1.82 Mn
Dec 31, 2024 1.82 Mn
Sep 30, 2024 -257,730.00
Sep 30, 2024 -257,730.00
Jun 30, 2024 1.65 Mn
Jun 30, 2024 1.65 Mn
Mar 31, 2024 317,119.00
Mar 31, 2024 317,119.00
Dec 31, 2023 9.66 Mn
Dec 31, 2023 9.66 Mn